Marshall Wace North America’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-43,671
| Closed | -$824K | – | 1412 |
|
|
2021
Q2 | $824K | Buy |
+43,671
| New | +$824K | ﹤0.01% | 1027 |
|
|
2019
Q4 | – | Sell |
-2,965
| Closed | -$45K | – | 1332 |
|
|
2019
Q3 | $45K | Sell |
2,965
-70,960
| -96% | -$1.08M | ﹤0.01% | 1168 |
|
|
2019
Q2 | $1.85M | Buy |
73,925
+72,014
| +3,768% | +$1.8M | 0.01% | 586 |
|
|
2019
Q1 | $43K | Buy |
+1,911
| New | +$43K | ﹤0.01% | 1290 |
|
|
2018
Q4 | – | Sell |
-31,241
| Closed | -$895K | – | 1501 |
|
|
2018
Q3 | $895K | Buy |
+31,241
| New | +$895K | 0.01% | 620 |
|